Sabby Volatility Warrant Master Fund Ltd. et al. v. Kevin J. Kennedy et al.

CourtDistrict Court, S.D. New York
DecidedDecember 16, 2025
Docket1:23-cv-00601
StatusUnknown

This text of Sabby Volatility Warrant Master Fund Ltd. et al. v. Kevin J. Kennedy et al. (Sabby Volatility Warrant Master Fund Ltd. et al. v. Kevin J. Kennedy et al.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sabby Volatility Warrant Master Fund Ltd. et al. v. Kevin J. Kennedy et al., (S.D.N.Y. 2025).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK

SABBY VOLATILITY WARRANT MASTER FUND LTD. et al., 23-CV-00601 (JGK) (RFT) Plaintiff,

-against- OPINION & ORDER KEVIN J. KENNEDY et al., Defendants.

ROBYN F. TARNOFSKY, United States Magistrate Judge: Plaintiffs Sabby Volatility Warrant Master Fund Ltd. (“Sabby”), SZOP Multistrat LP (“SZOP”), Alto Opportunity Master Fund SPC Segregated Master Portfolio B (“Alto”), and Hudson Bay Master Fund Ltd. (“Hudson Bay”), purchasers of common stock of Quanergy Systems, Inc. (“Quanergy”) in a public offering that closed on November 2, 2022 (the “Offering”), bring suit against Defendants Kevin J. Kennedy, Patrick Archambault, Jim Disanto, Karen Francis, Tamer Hassanein, Lisa Kelley, Thomas M. Rohrs, and Tianyue Yu, all former officers and/or directors of Quanergy, for alleged violations Sections 11 and 15 of the Securities Act of 1933, for failing to take reasonable care that there were no material misrepresentations or omissions in the registration statement and prospectus for the Offering (the “Offering Documents”). (See ECF 1, Compl. ¶¶ 1-2, 30-34, 131-32.) Defendants filed a motion for summary judgment (ECF 128), arguing, among other positions, that judgment should be granted in their favor based on the reasonable investigation affirmative defense, often called the due diligence defense. (See generally ECF 135, Defs.’ Mem. of Law in Supp. of Mot. for Summ. J. (“Defs.’ SJ Mem.”) (redacted version of ECF 129).) The summary judgment motion is fully briefed and will be decided by the Honorable John G. Koeltl; in support of that motion, Defendants submit expert testimony from Norman J. Harrison, who opines that it was “customary and appropriate” for Defendants to rely on outside counsel’s advice “in discharging their . . . obligations to conduct a reasonable investigation” for purposes of “develop[ing] a reasonable ground” to conclude that the statements in the Offering Documents were true and not misleading. (ECF 159-1, Expert Report of Norman J. Harrison (“Harrison Report”) ¶¶ 45, 61.)

Plaintiffs support their opposition to Defendants’ summary judgment motion with the expert report of John Levy, who rebuts Harrison’s opinions. (See ECF 144-58, Report of John Levy (“Levy Report”).) Pending before the Court is Defendants’ Motion To Disqualify Levy from providing opinions in this matter (“Motion To Disqualify”) (ECF 153). For the reasons set forth below, Defendants’ Motion To Disqualify is GRANTED IN PART, in that Levy may not opine (1) on the disputed factual

issue whether Defendants asked certain questions of their outside advisors about the need to disclose particular risks in the Offering Documents, or (2) on the credibility of any fact witnesses; the Motion To Disqualify is otherwise DENIED.1 0F FACTUAL BACKGROUND This factual background is taken from the admissible materials submitted by the parties; the facts set out below are either undisputed or presented “in the light most favorable to the . . . non-moving party.” In re AXA Equitable Life Ins. Co. COI Litig., 595 F. Supp. 3d 196, 209-10 (S.D.N.Y. 2022), reconsidered in unrelated part, No. 16-CV-0740 (JMF), 2022 WL 3018104 (S.D.N.Y. July 29, 2022).

1 “Because Daubert motions are nondispositive of the litigation, they are routinely determined by magistrate judges, subject to clear error review by the district judge.” Am. Empire Surplus Lines Ins. Co. v. J.R. Contracting & Env’t Consulting, Inc., 743 F. Supp. 3d 530, 533 (S.D.N.Y. 2024). In February 2022, Quanergy, a company that provided three-dimensional software solutions, among other products and services, became a public company listed on the New York Stock Exchange (“NYSE”). (See ECF 137, Defs.’ Rule 56.1 Statement of Undisputed Material Facts (“Defs.’ SUMF”) (redacted version of ECF 131) ¶¶ 1-2.) In March 2022, NYSE sent Quanergy a letter

describing the applicable listing standards. (See ECF 143, Pls.’ Counterstatement of Additional Material Facts (“Pls.’ CSAMF”) ¶ 5; ECF 151, Defs.’ Response to Pls.’ Counterstatement of Additional Material Facts (“Defs.’ RCSAMF”) (redacted version of ECF 150) ¶ 5.) To remain listed on NYSE, Quanergy was obligated, among other requirements, to maintain an average closing price of $1.00 per share over a 30-trading day period (the “Minimum Share Price Requirement”); maintain market capitalization of $50 million over a 30-trading day period (the “$50 Million Capitalization

Requirement”); and maintain a minimum market capitalization of $15 million over a 30-trading day period (the “$15 Million Capitalization Requirement”). (See ECF 143, Pls.’ CSAMF ¶ 5; ECF 151, Defs.’ RCSAMF ¶ 5.) A company may cure failure to comply with the Minimum Share Price Requirement and the $50 Million Capitalization Requirement within specified cure periods; however, there is no cure period for failing to comply with the $15 Million Capitalization Requirement, which leads to immediate suspension of trading and delisting. (See ECF 143, Pls.’

CSAMF ¶¶ 6, 7, 19; ECF 151, Defs.’ RCSAMF ¶¶ 6, 7, 19.) In June 2022, Quanergy announced that it had received a delisting notice for failing to comply with the Minimum Share Price Requirement; in July 2022, the company announced that it had received a delisting notice for failure to comply with the $50 Million Capitalization Requirement. (See ECF 143, Pls.’ CSAMF ¶¶ 6, 7; ECF 151, Defs.’ RCSAMF ¶¶ 6, 7.) In June 2022, Quanergy began exploring possible financing options, including a debt financing and a merger or sale. (See ECF 137, Defs.’ SUMF ¶ 7; ECF 143, Pls.’ CSAMF ¶¶ 10-11, 13; ECF 151, Defs.’ RCSAMF ¶¶ 10-11, 13.) In late August 2022, Quanergy retained an investment bank, Maxim Group LLC (“Maxim”), to explore a public offering. (See id. ECF 137, Defs.’ SUMF ¶ 13.) Quanergy’s primary outside counsel, the Cooley LLP law firm (“Cooley”), was “deeply involved in Quanergy’s Offering

process.” (Id. ¶ 19.) On October 6, 2022, Quanergy announced that it had initiated a reverse stock split in order to increase its share price to comply with the Minimum Share Price Requirement. (See ECF 143, Pls.’ CSAMF ¶ 8; ECF 151, Defs.’ RCSAMF ¶ 8.) By the start of trading on October 12, 2022, Quanergy’s market capitalization had fallen below $15 million. (See ECF 151, Defs.’ RCSAMF ¶ 20.) The next day, Quanergy announced that it had initiated efforts to preserve its capital resources,

including a restructuring plan and layoffs. (See ECF 143, Pls.’ CSAMF ¶ 9; ECF 151, Defs.’ RCSAMF ¶ 9.) On October 18, 2022, after Quanergy’s market capitalization declined to approximately $9 million, Defendant Archambault received an email from NYSE indicating that Quanergy risked immediate suspension and delisting due to noncompliance with the $15 Million Capitalization Requirement. (See ECF 143, Pls.’ CSAMF ¶ 21; ECF 151, Defs.’ RCSAMF ¶ 21.) Jerry Allison, then the

General Counsel of Quanergy, and outside counsel were copied on the email. (See ECF 143, Pls.’ CSAMF ¶ 22; ECF 151, Defs.’ RCSAMF ¶ 22.) On October 26, 2022, Defendant Archambault distributed a spreadsheet that described six potential Offering scenarios, four of which resulted in Quanergy’s market capitalization dropping below $15 million. (See ECF 143, Pls.’ CSAMF ¶¶ 23-24; ECF 151, Defs.’ RCSAMF ¶¶ 23-24.) The parties dispute whether Archambault shared the substance of the spreadsheet with Quanergy’s full Board of Directors: Plaintiffs say there is no evidence that he did. (See ECF 143, Pls.’ CSAMF ¶¶ 23, 25; ECF 151, Defs.’ RCSAMF ¶¶ 23, 25.) On October 28, 2022, Defendants Archambault and Kennedy participated in a bringdown due diligence call with the Maxim bankers, who asked Quanergy to provide “any material updates

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Riegel v. Medtronic, Inc.
451 F.3d 104 (Second Circuit, 2006)
Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
General Electric Co. v. Joiner
522 U.S. 136 (Supreme Court, 1997)
Kumho Tire Co. v. Carmichael
526 U.S. 137 (Supreme Court, 1999)
Casey v. MERCK & CO., INC.
653 F.3d 95 (Second Circuit, 2011)
United States v. Paul A. Bilzerian
926 F.2d 1285 (Second Circuit, 1991)
United States v. Randolph Jakobetz
955 F.2d 786 (Second Circuit, 1992)
Joan S. Borawick v. Morrie Shay and Christine Shay
68 F.3d 597 (Second Circuit, 1995)
United States v. Roxanne Lumpkin, Mario Williams
192 F.3d 280 (Second Circuit, 1999)
United States v. Tin Yat Chin, AKA Tan C. Dau
371 F.3d 31 (Second Circuit, 2004)
United States v. Williams
506 F.3d 151 (Second Circuit, 2007)
In Re Rezulin Products Liability Litigation
309 F. Supp. 2d 531 (S.D. New York, 2004)
UMG Recordings, Inc. v. Lindor
531 F. Supp. 2d 453 (E.D. New York, 2007)
In Re Zyprexa Products Liability Litigation
489 F. Supp. 2d 230 (E.D. New York, 2007)
Highland Capital Management, L.P. v. Schneider
379 F. Supp. 2d 461 (S.D. New York, 2005)
Primavera Familienstifung v. Askin
130 F. Supp. 2d 450 (S.D. New York, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
Sabby Volatility Warrant Master Fund Ltd. et al. v. Kevin J. Kennedy et al., Counsel Stack Legal Research, https://law.counselstack.com/opinion/sabby-volatility-warrant-master-fund-ltd-et-al-v-kevin-j-kennedy-et-al-nysd-2025.